SurgLine International, Inc.
SGLN · OTC
7/31/2012 | 7/31/2011 | 7/31/2010 | 7/31/2009 | |
|---|---|---|---|---|
| Revenue | $114 | $0 | $0 | $3 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $75 | $0 | $29 | $28 |
| Gross Profit | $39 | $0 | -$29 | -$24 |
| % Margin | 34.4% | – | – | -770.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2,121 | $331 | $348 | $452 |
| SG&A Expenses | $2,121 | $331 | $348 | $452 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $53 | $44 | $68 |
| Operating Expenses | $2,121 | $384 | $364 | $493 |
| Operating Income | -$2,082 | -$384 | -$393 | -$517 |
| % Margin | -1,832.4% | – | – | -16,329.8% |
| Other Income/Exp. Net | -$655 | $75 | $393 | $517 |
| Pre-Tax Income | -$2,737 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2,737 | -$307 | -$772 | -$787 |
| % Margin | -2,408.9% | – | – | -24,857.9% |
| EPS | -0.001 | -0.01 | -0.01 | -0.01 |
| % Growth | 95% | 0% | 0% | – |
| EPS Diluted | -0.001 | -0.01 | -0.01 | -0.01 |
| Weighted Avg Shares Out | 5,346,848 | 482,778 | 326,246 | 215,342 |
| Weighted Avg Shares Out Dil | 5,346,848 | 482,778 | 326,246 | 215,342 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $2 |
| Interest Expense | $276 | $221 | $205 | $346 |
| Depreciation & Amortization | $1 | $22 | $52 | $52 |
| EBITDA | -$2,460 | -$362 | -$341 | -$465 |
| % Margin | -2,165.1% | – | – | -14,687.3% |